Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy

PURPOSE: Primary prophylaxis with granulocyte colony-stimulating factor can effectively prevent febrile neutropenia (FN) during breast cancer treatment. The aims of this study were to evaluate the incidence of FN and the ANC profile in patients undergoing chemotherapy and pegfilgrastim primary proph...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jihyoun, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Kim, Sung Yong, Lee, Min Hyuk, Lim, Cheol Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931931/
https://www.ncbi.nlm.nih.gov/pubmed/29732352
http://dx.doi.org/10.4174/astr.2018.94.5.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931931/
https://www.ncbi.nlm.nih.gov/pubmed/29732352
http://dx.doi.org/10.4174/astr.2018.94.5.223

Ejemplares similares